Nerol

Pharmacology & Research

Nerol is an acyclic monoterpene alcohol and the cis (Z) isomer of geraniol — distinct from neral (the corresponding aldehyde) and from nerolidol (a sesquiterpene). It carries a soft, sweet, rose-like scent and is a high-volume GRAS flavour and fragrance ingredient. There is a modest but real body of nerol-isolate preclinical work — antifungal being the deepest — but the honest headline holds: no human trials, no dedicated pharmacokinetic study, and much surrounding literature is essential-oil-level. All efficacy evidence is in-vitro or rodent.

1. Antifungal

Nerol shows reproducible activity against Candida albicans (in vitro and in a mouse model) ^{1Reference 1Wang Z et al. · 2020In vitroActivities of nerol against Candida albicans in vitro and in vivoView study →} and plant/postharvest pathogens such as Fusarium oxysporum and Valsa mali ^{2Reference 2Ji J et al. · 2024Nerol as a novel antifungal agent: inhibitory effects on Fusarium oxysporum, Pestalotiopsis neglecta and Valsa maliView study →}. The mechanism is consistent: membrane and mitochondrial disruption → ROS accumulation, Ca²⁺ overload and apoptosis-like death ^{3Reference 3Tian J et al. · 2018Nerol-induced apoptosis associated with ROS generation and Ca²⁺ overload in Aspergillus flavusView study →}.

Gap: almost entirely in-vitro/phytopathology; the only whole-animal work is a Candida mouse model ^{1Reference 1Wang Z et al. · 2020In vitroActivities of nerol against Candida albicans in vitro and in vivoView study →}, potency is modest, and volatility limits systemic use.

2. Antibacterial / anti-quorum-sensing

Nerol inhibited quorum sensing and acted therapeutically in a mouse Acinetobacter baumannii pneumonia model ^{4Reference 4Lu Q et al. · 2026Nerol as an anti-quorum-sensing and therapeutic agent against Acinetobacter baumannii pneumonia. iScience. https://pubmed.ncbi.nlm.nih.gov/42063562/View study →}, and works synergistically with carvacrol against nosocomial pathogens ^{5Reference 5Kasthuri T et al. · 2022Synergistic antiseptic property of carvacrol and nerol against nosocomial pathogensView study →}.

Gap: a single in-vivo study; the rest is in-vitro MIC/synergy work, not systemic efficacy in humans ^{4,5Reference 4Lu Q et al. · 2026Nerol as an anti-quorum-sensing and therapeutic agent against Acinetobacter baumannii pneumonia. iScience. https://pubmed.ncbi.nlm.nih.gov/42063562/View study →Reference 5Kasthuri T et al. · 2022Synergistic antiseptic property of carvacrol and nerol against nosocomial pathogensView study →}.

3. Antioxidant / organ-protection

In rodents, nerol gave antioxidant/anti-apoptotic protection against CCl₄-induced liver injury ^{6Reference 6Mondal M et al. · 2023AnimalProtective effects of nerol against carbon-tetrachloride liver toxicity in Sprague-Dawley ratsView study →} and doxorubicin-induced heart failure ^{7Reference 7He ML et al. · 2025AnimalNerol attenuates doxorubicin-induced heart failure by inhibiting cardiomyocyte apoptosis in ratsView study →}.

Gap: rodent + in-vitro only, often at high doses, with surrogate organ-injury endpoints rather than clinical outcomes ^{6,7Reference 6Mondal M et al. · 2023AnimalProtective effects of nerol against carbon-tetrachloride liver toxicity in Sprague-Dawley ratsView study →Reference 7He ML et al. · 2025AnimalNerol attenuates doxorubicin-induced heart failure by inhibiting cardiomyocyte apoptosis in ratsView study →}.

4. CNS / cognitive

Nerol improved cognition in a vascular-dementia rat model by reducing mitochondrial oxidative stress and hippocampal senescence ^{8Reference 8Yang J et al. · 2026AnimalNerol ameliorates cognitive dysfunction in vascular-dementia rats by inhibiting mitochondrial oxidative stressView study →}.

Gap: one rodent study — no isolated-nerol anxiolytic/sedative trial exists, so any “calming” claim is essential-oil-level, not nerol-specific ^{8Reference 8Yang J et al. · 2026AnimalNerol ameliorates cognitive dysfunction in vascular-dementia rats by inhibiting mitochondrial oxidative stressView study →}.

Mechanisms

Target / pathway	Effect	Relevant to
Fungal/bacterial cell membrane	permeabilisation, loss of integrity	antifungal, antibacterial
Mitochondria + ROS + Ca²⁺	dysfunction, ROS burst, Ca²⁺ overload → apoptosis-like death	antifungal (fungicidal mechanism)
Quorum sensing (bacterial)	signalling/virulence suppression	antibacterial
Nrf2 / antioxidant defences	↑ antioxidant response, ↓ oxidative injury	organ-protection, CNS

Only the membrane-disruption and mitochondrial/ROS/Ca²⁺ actions are reproduced across multiple studies; the rest are single-report mechanisms.

Pharmacokinetics

No dedicated pharmacokinetic study of isolated nerol exists — a genuine gap. As the cis isomer of geraniol, its ADME is inferred, not measured: expected to be highly volatile, rapidly absorbed and rapidly cleared via allylic oxidation to acidic metabolites (nerolic/geranic-acid-type products), with short systemic residence and low sustained exposure — the same limitation that constrains geraniol. This inferred profile is the central caveat separating nerol’s in-vitro/topical potency from any systemic use.

Clinical trials

There are no human trials of isolated nerol for any indication. All efficacy evidence is in-vitro or rodent.

Last checked: July 2026.

Toxicity & Safety

Nerol (CAS 106-25-2) is a long-established FEMA/FDA GRAS flavouring and high-volume fragrance ingredient; the RIFM fragrance-ingredient safety assessment concluded it is safe at current use levels for the evaluated endpoints ^{9Reference 9Api AM et al. · 2023RIFM fragrance ingredient safety assessment, nerol, CAS 106-25-2View study →}, and systemic toxicity at flavouring exposure is low. Two honest caveats belong on the page. First, nerol is a recognised fragrance contact allergen — included among the EU’s expanded list of labelled fragrance allergens — and a mild skin sensitiser; undiluted material can irritate, and air-oxidation raises allergenicity. Second, at higher concentrations in vitro it was genotoxic/cytotoxic in human PBMC and HepG2/C3A cells ^{10Reference 10Silva BO et al. · 2021Genotoxicity induced by nerol using human PBMC and HepG2/C3A cells as a modelView study →}; these are supraphysiologic findings, not evidence of harm at food/fragrance exposure, but they justify keeping the tone measured rather than “harmless.”

Pregnancy & lactation

Dietary/fragrance amounts fine; avoid concentrated or supplemental use. No reproductive or developmental toxicity data exist for isolated nerol; dietary and normal cosmetic exposure is not a concern, but isolated/therapeutic doses should be avoided in pregnancy and lactation given the absence of data and the in-vitro genotoxicity signal ^{10Reference 10Silva BO et al. · 2021Genotoxicity induced by nerol using human PBMC and HepG2/C3A cells as a modelView study →}.

Dosage

There is no established human dose for isolated nerol, and nothing here is a recommendation. Human exposure is limited to food-flavouring (GRAS) and fragrance levels ^{9Reference 9Api AM et al. · 2023RIFM fragrance ingredient safety assessment, nerol, CAS 106-25-2View study →}; preclinical efficacy used rodent doses or in-vitro concentrations far above dietary intake. Any topical antimicrobial/antifungal use should account for its sensitiser status.

References